← Search

Data · dataset · 2026

Congress Presentation: IMS 2026 Rapid onset of action and sustained effect of elinzanetant in women with adjuvant endocrine therapy-associated VMS: results from the OASIS-4 Phase III clinical trial

Listed in ZivaHub and Deakin Research Online and DMU Figshare — shown once because both records carry DOI 10.71943/bayer.figshare.33995472.v1

<p dir="ltr">EZN reduced VMS frequency from 1 day following treatment initiation, with substantial reductions 3 days after start of therapy.

Description

Sleep improved within 1 week. The results are similar to data from the OASIS-1 and -2 trials in naturally or surgically postmenopausal women and support elinzanetants potential to provide rapid relief of VMS and sleep disturbances.</p>

Links

Where it is published

Catalogue records · 1

Topics

Provenance · 3 source records, 7 field assertions
SourceKeyLast seenRaw
ZivaHuboai:figshare.com:article/3399547213 d agoJSON v1
Deakin Research Onlineoai:figshare.com:article/3399547213 d agoJSON v1
DMU Figshareoai:figshare.com:article/3399547213 d agoJSON v1
FieldAssertionExtractorEvidence
concepts[field].local:field:earth-environmentalmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:earth-environmentalmapping · figshare dmu ac ukconnector:figshare_dmu_ac_uk@1.0.0
concepts[field].local:field:earth-environmentalmapping · dro deakin edu auconnector:dro_deakin_edu_au@1.0.0
descriptionsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/description
license_textsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
publication_datesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
titlesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/title